Navigation Links
2011 AAPS Annual Meeting and Exposition
Date:8/4/2011

WHO: American Association of Pharmaceutical Scientists (AAPS)

WHAT: Scientists from around the world will gather to share their insights and latest scientific discoveries in order to improve health through advances in pharmaceutical sciences at the 2011 AAPS Annual Meeting and Exposition.

In recognition of AAPS's 25th anniversary, this year's meeting, "The Next 25 Years," will feature more than 90 programming sessions, including more than 60 symposia and roundtables.

WHEN: October 23 27, 2011

WHERE: Walter E. Washington Convention Center
801 Mount Vernon Place, NW
Washington, D.C. 20001

KEYNOTE: U.S. Food and Drug Administration's Janet Woodcock M.D., director of the Center for Drug Evaluation and Research, will provide her views on regulation in the future.

For the most up-to-date program information, please visit: http://www.nxtbook.com/nxtbooks/aaps/annualmeeting2011_preprogram/#/0


'/>"/>

Contact: Stacey May
MayS@aaps.org
703-248-4740
American Association of Pharmaceutical Scientists
Source:Eurekalert

Page: 1

Related medicine news :

1. Heart Disease Prevention May Save Billions Annually in U.S.
2. Largest Ob/Gyn Group Backs Annual Mammograms in 40s
3. ACR, SBI support updated ACOG recommendations that women begin annual mammograms at age 40
4. Sociologists to explore social conflict at annual meeting in Las Vegas, Aug. 20-23
5. More Than 200,000 Suffer Cardiac Arrest in Hospitals Annually
6. Nature Publishing Group supports ASCB Childcare Awards for scientist-parents at annual meeting
7. AOSSM presents prestigious research awards at annual meeting
8. Female mate choice enhances offspring fitness in an annual herb
9. 200,000 patients treated for cardiac arrest annually in US hospitals, Penn study shows
10. Global Health Council opens 38th annual international conference in Washington
11. European Society of Human Reproduction and Embryology Annual Meeting July 3-6, 2011, Stockholm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: